IL6 and cancer: The recent finding that peripheral immune events strongly activate the body-brain, vagal-based circuits to inform the brain of emerging inflammatory responses [Jin et al., 2024] offers an exciting new framework to modulate immunotherapy for cancer and is consistent with the proposed use of VNS to control cancer within and outside of the brain, targeting pro-inflammatory cytokines, primarily IL-6.